探索呼吸机相关肺炎:从回顾性研究中获得的微生物线索和生物标志物见解
Ahmed M Gouda1, Ashraf E Sileem2, Hanan M Elnahas3
1Department of Pharmacy Practice, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Medicina (Kaunas, Lithuania)
|August 29, 2024
概括
克莱布西拉肺炎和 Pseudomonas aeruginosa 在呼吸机相关肺炎 (VAP) 中很常见. 疾病严重程度得分和C反应性蛋白水平有效预测VAP患者的存活率,指导管理策略.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 呼吸机相关性肺炎 (VAP) 是机械呼吸器危急病患者的常见并发症.
- 由于抗微生物药物耐药性不断上升和潜在的患者不良结果,VAP带来了挑战.
研究的目的:
- 为了研究VAP的微生物光谱.
- 评估生物标志物和疾病严重程度评分对VAP患者生存的预测价值.
主要方法:
- 对130名VAP患者进行了回顾性队列研究.
- 支气管支气管洗液 (BAL) 的微生物分析.
- 测量C反应蛋白 (CRP) 和前素 (PCT) 的水平.
- 测序器官衰竭评估 (SOFA) 和APACHE II分数的计算.
主要成果:
- 克莱布西拉肺炎 (50.7%) 和 Pseudomonas aeruginosa (27.69%) 是主要的 VAP 病原体.
- SOFA 和 APACHE II 的预测死亡率得分显著 (p < 0.0001).
- 较高的CRP水平与生存率降低有关 (OR:0.980,p = 0.001).
结论:
- 这项研究阐明了导致VAP的常见微生物代理.
- 生物标志物如CRP和严重性评分 (SOFA,APACHE II) 对于预测VAP患者存活率至关重要.
- 调查结果强调需要有针对性的管理,以解决微生物耐药性和改善VAP结果.
更多相关视频
09:19Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction
Published on: June 1, 2022
4.0K
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
8.8K
相关概念视频
01:30Pneumonia I: Introduction
214
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
01:30Pneumonia III: Complications and Assessment
189
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
189
01:28Pneumonia IV: Management
311
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
311
01:29Mechanical Ventilation I: Indication and Settings
220
Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
220